Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection

Scientific Reports
Keith MeyerRanjit Ray

Abstract

Viral entry requires co-operative interactions of several host cell factors. Interferon (IFN) and the IFN-stimulated genes (ISGs) play a central role in antiviral responses against hepatitis C virus (HCV) infection. We examined the effect of interferon-α inducible protein 6 (IFI6) against HCV infection in human hepatoma cells. HCV RNA level or infectious foci were inhibited significantly by ectopic expression of IFI6. IFI6 impaired CD81 co-localization with claudin-1 (CLDN1) upon HCV infection or CD81 cross-linking by specific antibody. Activation of epidermal growth factor receptor (EGFR), a co-factor involved in CD81/CLDN1 interactions, was reduced in IFI6 expressing cells in response to HCV infection or CD81 cross linking by antibody, but not by treatment with EGF. Taken together, the results from our study support a model where IFI6 inhibits HCV entry by impairing EGFR mediated CD81/CLDN1 interactions. This may be relevant to other virus entry processes employing EGFR.

References

Jan 1, 1992·Pharmacology & Therapeutics·A N McNair, I M Kerr
Nov 1, 1994·Trends in Biochemical Sciences·G DaumU R Rapp
Dec 1, 1995·Molecular Reproduction and Development·M Marshall
Dec 1, 1995·Molecular Reproduction and Development·F McCormick
Oct 30, 1998·Science·P PileriS Abrignani
Apr 21, 1999·Current Opinion in Cell Biology·P O HackelA Ullrich
Nov 30, 1999·Trends in Pharmacological Sciences·E ZwickA Ullrich
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Jan 5, 2002·The Journal of Biological Chemistry·Markus KubicekManuela Baccarini
Dec 12, 2002·Progress in Biophysics and Molecular Biology·L González-MariscalB E Jaramillo
Apr 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Haizhen ZhuChen Liu
Jan 15, 2004·Journal of Virology·Jie ZhangJane A McKeating
Apr 14, 2006·Journal of Virology·Tatsuo KandaRatna B Ray
Apr 28, 2006·Journal of Virology·Claire Bertaux, Tatjana Dragic
Jul 1, 2006·Journal of Virology·Emmanuelle BlanchardYves Rouillé
Sep 8, 2007·The Journal of Clinical Investigation·Venugopalan CheriyathErnest C Borden
Dec 19, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gary M ReynoldsJane A McKeating
Jun 24, 2008·Nature Reviews. Molecular Cell Biology·Antoine E Karnoub, Robert A Weinberg
Jun 27, 2008·Journal of Virology·Michelle J FarquharJane A McKeating
Sep 9, 2008·The Journal of Biological Chemistry·Mengwei ZangZhijun Luo
Apr 9, 2010·The Journal of Biological Chemistry·Helen J HarrisJane A McKeating
Dec 3, 2010·Current Opinion in Immunology·Su-Yang LiuGenhong Cheng
Jul 23, 2011·Genes & Cancer·David MatallanasWalter Kolch
Oct 7, 2011·Journal of Virology·Amit RaychoudhuriRatna B Ray
Feb 10, 2012·Journal of Virology·Michelle J FarquharJane A McKeating
Aug 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·John W SchogginsCharles M Rice
Sep 22, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Courtney WilkinsMichael Gale
Mar 23, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Joachim LupbergerThomas F Baumert

❮ Previous
Next ❯

Citations

Jan 6, 2016·International Journal of Molecular Sciences·Karin Komposch, Maria Sibilia
Nov 6, 2015·Viruses·Mirjam B ZeiselCatherine Schuster
Jul 18, 2015·PloS One·Shuanghu LiuCurt H Hagedorn
Sep 2, 2017·Vaccines·Ana Maria Ortega-Prieto, Marcus Dorner
Feb 15, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Young-Chan KwonRanjit Ray
May 23, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·AnggakusumaEike Steinmann
Nov 20, 2015·Journal of Virology·Shubham ShrivastavaRatna B Ray
Sep 11, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xiao LiuRaymond T Chung
Jul 5, 2019·Cancers·Wenhui WangChaoyong He
Nov 4, 2015·World Journal of Hepatology·Jingya LyuKoji Murao
Sep 19, 2019·Science Signaling·Gholamreza Haqshenas, Christian Doerig
Mar 24, 2018·F1000Research·John W Schoggins
Mar 28, 2020·International Journal of Molecular Sciences·Juan P Unfried, P Fortes
Jul 29, 2017·Molecular Cancer Research : MCR·Corina N A M van den HeuvelWilliam P J Leenders
Nov 20, 2020·Journal of Virology·Yung-Ju YehJu-Chien Cheng
Dec 19, 2020·International Journal of Molecular Sciences·Ana-Belén Blázquez, Juan-Carlos Saiz
Apr 23, 2021·Journal of Virology·Smitha Srinivasachar Badarinarayan, Daniel Sauter
Jun 22, 2021·The Journal of Allergy and Clinical Immunology·Kirstin JansenMübeccel Akdis

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
co-immunoprecipitation
FACS
GTPase
transfection
flow cytometry
confocal microscopy

Software Mentioned

ImageJ
ExtremeGENE
FlowJo
Olympus Fluoview
CellQuest

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.